Weak muscle mass - Osteoporosis
Conditions
Interventions
The experimental group 8:Drug combination exercise prescription
The experimental group 9:Medicine combined with exercise prescription and winning body sheng Bone prescription
The experimental group 2:Drug therapy combined with low frequency pulsed electromagnetic fields
The experimental group 1:Drug therapy combined with whole body vibration training
Conventional treatment group1:Oral calcitol, alfacalccitol capsules and alendronate tablets
Pharmacotherapy group:Oral anti-osteoporosis drugs
The experimental group 7:Combination of drugs and winning body sheng Gu fang
The experimental group 6:Drug therapy combined with whole body vibration training and low frequency pulsed electromagnetic fields
Drugs combined with baduanjin group:Oral anti-osteoporosis drugs combined with baduanjin
The experimental group 3:Drug therapy combined with whole body vibration training and low frequency pulsed electromagnetic fields
The experimental group 5:Drug therapy combined with low frequency pulsed electromagnetic fields
Conventional treatment group3:Calcium, vitamin D and NSAIDs
Conventional treatment group2:Oral calcitol, alfacalccitol capsules and alendronate tablets
The experimental group 4:Drug therapy combined with whole body vibration training
Sponsors
Red Union Hospital affiliated to Xi 'an Jiaotong University
Eligibility
Sex/Gender
All
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. The age ranges from 55 to 75 years old with normal vision 2. It conforms to the clinical diagnosis of sarcopenia and osteoporosis and is not complicated with other diseases. 3. Understand the research proposal, agree and sign the informed consent 4. Follow up
Exclusion criteria
Exclusion criteria: 1. Severe hypertension, hypotension, heart disease, vascular disease and epilepsy 2. Thrombosis or a history of thrombosis in the last 6 months 3. Various operations are not recovered 4. Joint trauma, fracture, muscle strain, serious joint deformation, difficult squatting 5. Bone and joint diseases affecting movement and walking have serious physical diseases; 6. Patients with weak health, severe balance disorder or vertigo, mental illness or family history of mental illness dementia and cognitive dysfunction 7. You have an implant 8. Suffering from gout, rheumatoid disease, poor glycemic control in diabetes, or other diseases that seriously affect bone metabolism 9. Lumbar disc herniation or slip, lumbar nerve tube stenosis or compression.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body mass index;bone alkaline phosphatase;Sit up time;Muscle strength of extremities;C-terminal peptide of type I collagen;Hip bone density;Crus surrounds degrees;appraisal of life quality;Lumbar bone density;Thigh circumference degrees;Amino terminal propeptide of type ? procollagen;The blood concentration of phosphorus;grip;Blood calcium concentration;activities of daily living;Visual analog rating Scale;C-terminal peptide of type ? collagen;6 m pace; | — |
Countries
China
Contacts
Public ContactXi fang Liu
Red Union Hospital affiliated to Xi 'an Jiaotong University
Outcome results
None listed